Storys aus Israel

Filtern
  • 12.05.2021 – 15:25

    News Direct

    GROUNDWORK BIOAG RAISES $11 MILLION TO ADVANCE BIOAGRICULTURE GLOBALLY

    MAZOR, ISRAEL (ots) - --News Direct-- - Accelerating Production Capacity to Meet Demand for Regenerative Agriculture Products - Serving One Million Acres (400 KHa) in 2021 Groundwork BioAg announced today it raised $11 million in venture capital financing led by Ibex Investors with the participation of ProDelta and Future Foodways. Previous investors, including MoreVC, ...

  • 10.05.2021 – 19:31

    Nayax

    Nayax Announces the Pricing of its Initial Public Offering

    Herzliya, Israel (ots/PRNewswire) - Nayax Ltd. ("Nayax") announced today the pricing of its global initial public offering of 63,500,000 ordinary shares at a price per share of ILS 10.50 (approx. USD 3.25). The offering comprises 44,000,000 ordinary shares by Nayax and an aggregate of 19,500,000 ordinary shares by three existing shareholders (the "Selling Shareholders"). In addition, Nayax has granted the underwriters a ...

  • 28.04.2021 – 19:12

    Nayax

    Nayax announces the launch of its initial public offering

    Herzliya, Israel (ots/PRNewswire) - Nayax Ltd. ("Nayax") announced today that it has commenced a global initial public offering of its ordinary shares to institutional investors. The offering in Israel is being made pursuant to a prospectus filed with the Israel Securities Authority which is expected to be approved. Nayax proposes to sell up to 44,000,000 of its ordinary shares in the offering, and three existing ...

  • 27.04.2021 – 10:00

    Medasense Biometrics Ltd

    Pain Monitoring Technology (NOL) is Shown to Reduce Postoperative Pain and Health Costs

    Ramat Gan, Israel (ots/PRNewswire) - A new study from Leiden University in the Netherlands has found that monitoring pain response levels during surgery with NOL® technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Extrapolating the results of this study, an economic analysis has shown that by facilitating reduced postoperative pain, using ...

  • 19.04.2021 – 11:47

    Vidac Pharma LTD

    Vidac Pharma Secures EUR 20m Capital Commitment From GEM

    Ness-Ziona, Israel (ots/PRNewswire) - Vidac Pharma LTD (Vidac) a clinical-stage Israel biopharmaceutical company, announced today that it has signed an agreement with GEM Global Yield LLC SCS ("GEM") a Luxemburg-based private alternative investment group for a EUR 20 million capital commitment. Under the agreement, GEM commits to provide Vidac with a share subscription facility of up to EUR 20 million for a 36-month term ...